首页> 外文期刊>Pathologica >Molecular alterations in thyroid lesions-, a review of diagnostic applications to fine needle aspiration (FNA) samples
【24h】

Molecular alterations in thyroid lesions-, a review of diagnostic applications to fine needle aspiration (FNA) samples

机译:甲状腺病变中的分子改变-细针抽吸(FNA)样品的诊断应用综述

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Many studies published in the past several years have shown that molecular analysis of fine needle aspiration (FNA) thyroid specimens is both feasible and useful M1. In fact, the type of genetic alterations that occur in thyroid cancer, the clinical context and the very nature of FNA samples, make the latter ideally suited for molecular analysis. This is the case for several reasons. Thyroid tumors show a remarkable correlation between phenotype (i.e. tumor type) and genotype (genetic alterations), a correlation that is closer than that observed in other epithelial neoplasms. Carcinomas with papillary architecture (classic papillary carcinoma or its tall cell variant) are characterized by a high prevalence of two specific molecular alterations: BRAF mutation (BRAFV600E), in 30-70% of cases and RET/PTC rearrangement, in 20-40%.
机译:过去几年中发表的许多研究表明,对细针穿刺(FNA)甲状腺标本进行分子分析既可行又有用。实际上,甲状腺癌中发生的遗传改变的类型,临床背景以及FNA样本的性质使得后者非常适合进行分子分析。出现这种情况有几个原因。甲状腺肿瘤在表型(即肿瘤类型)和基因型(遗传改变)之间显示出显着的相关性,这种相关性比在其他上皮肿瘤中观察到的相关性更紧密。具有乳头状结构的癌(经典乳头状癌或其高细胞变体)的特征是两种特定分子改变的高发生率:BRAF突变(BRAFV600E)(占30-70%)和RET / PTC重排(占20-40%) 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号